Anetumab ravtansine showed additive interaction with doxorubicin in the ovarian cancer cell line OVCAR-8, characterized by BRCA1 methylation [41], in vitro, as indicated by combination indices (CI) between 0.8 and 1.2 [42] in five repeated experiments (Figure 5A). This evidence concerns the gene BRCA1 and ovarian cancer.